FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080399 [Registered on: 12/02/2025] Trial Registered Prospectively
Last Modified On: 08/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparing Hyaluronidase and Dexamethasone Injections for reducing Pain, Swelling and inability to open mouth after Wisdom Tooth Surgery. 
Scientific Title of Study   Evaluation of Hyaluronidase Vs Dexamethasone Submucosal Injections in Reducing Post Operative Sequalae after Disimpaction of Bilateral Impacted Mandibular Third Molar - A Split Mouth Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Edara Samuel 
Designation  Post Graduate 
Affiliation  Dr.Ntr university of health sciences 
Address  Department of oral and maxillofaciaL surgery. Room no: 3 .Sibar institute of dental sciences

Guntur
ANDHRA PRADESH
522509
India 
Phone  9704365500  
Fax    
Email  samuel.edara@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr P Srinivas Chakravarthi  
Designation  Professor 
Affiliation  Dr.Ntr university of health sciences 
Address  Department of oral and maxillofaciaL surgery. Room no: 3 .Sibar institute of dental sciences

Guntur
ANDHRA PRADESH
522509
India 
Phone  9392103703  
Fax    
Email  pscomf@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Edara Samuel 
Designation  Post Graduate 
Affiliation  Dr.Ntr university of health sciences 
Address  Department of oral and maxillofaciaL surgery. Room no: 3 .Sibar institute of dental sciences

Guntur
ANDHRA PRADESH
522509
India 
Phone  9704365500  
Fax    
Email  samuel.edara@gmail.com  
 
Source of Monetary or Material Support  
Sibar Institute of dental sciences, Takellepadu, Guntur, Andhra Pradesh 522509 India 
 
Primary Sponsor  
Name  Edara samuel 
Address  Department of oral and maxillofacial surgery ,Room no :3 Sibar institute of dental sciences ,Takellapadu,Guntur, Andhra Pradesh 522509 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Edara samuel  Sibar institute of dental sciences  Department of oral and maxillofaciaL surgery. Room no: 3.
Guntur
ANDHRA PRADESH 
9704365500

samuel.edara@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee Sibar institute of dental sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K011||Impacted teeth,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Dexamethasone  1ml , one time, Parenteral route-submucosal injection for one minute slowly.  
Intervention  Hyaluronidase  1500 International Units 1ml , one time, Parenteral route-submucosal injection for one minute slowly.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  44.00 Year(s)
Gender  Both 
Details  Age group 18-40 years
Healthy and Non-Diabetic patients.
Patients falling under physical status classification (American society of Anesthesiologists) ASA 1 and ASA 2
individuals
Compliance with the study following voluntary participation.
Patients with similar class of Bilateral Impacted Mandibular molar teeth (mesioangular, class-1,position A or B)
 
 
ExclusionCriteria 
Details  History of adverse effects to any drugs to be administered during the study period.
Pregnant or lactating woman.
Long-term use of drugs that affect systemic inflammatory response.
Patients who are not willing to be involved in the study.


 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Post operative pain, mouth opening and swelling  Pre operative day 1, post operative days 3rd, 7th ,14th day 
 
Secondary Outcome  
Outcome  TimePoints 
No Secondary outcome measured .Any adverse events will be noted  Pre operative day 1, post operative days 3rd, 7th ,14th day 
 
Target Sample Size   Total Sample Size="44"
Sample Size from India="44" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   01/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Aim of the proposal:

To evaluate the efficacy of submucosal Hyaluronidase vs Dexamethasone injections in reducing postoperative sequalae like Pain, Mouth opening and Swelling after disimpaction of bilateral mandibular third molar.

 Specific Objectives:

To assess and compare the effectiveness of Hyaluronidase and Dexamethasone in post- operative pain control.

2)      To assess and compare the effectiveness of Hyaluronidase and Dexamethasone in Mouth opening.

3)      To assess and compare the effectiveness of Hyaluronidase and Dexamethasone in reducing facial swelling.

 Materials &Methods:

 Source & Selection of Samples:

 The present study will be conducted in the department of oral and maxillofacial surgery. 44 patients who met with inclusion criteria will be selected from out-patient department of oral and maxillofacial surgery.

Summary :

Patients reporting to the department of oral and maxillo-Facial Surgery during the study period (Duration-18 months) for bilateral mandibular third molar surgery are included based on inclusion criteria,.Study will be explained & written informed consent will be taken, Randomization is done alternatively into two groups, Group-1 Administration of  submucosal  Hyaluronidase inj(1500 IU) at surgical site(mesial,distal and buccal) 1ml after Surgical procedure is done under local Anaesthesia and flap closure with silk sutures. Group-2 Administration of  submucosal  Dexamethasone inj (4mg) at surgical site site(mesial,distal and buccal) 1ml after Surgical procedure is done under local Anaesthesia and flap closure with silk sutures. Pain, Mouth opening and Facial swelling will be measured Pre-operative and compared with post-operative day 3 & day  7 & day 14. 1) The Pain score will be assessed using Visual Analog scale 2) Mouth opening measured with Digital Vernier calipers3) Facial swelling measured with measuring thread as three linear measurements.a) Tragus – Oral commissure b) Tragus – Pogonion c) Lateral Canthus - Gonion. All the 3 linear measurements are summed up and calculated. 

Statistical test: 1) Repeated measures of ANOVA at different time intervals : To calculate the outcome variables in  the two groups and comparison between the groups. 2) Mann Whitney test for measuring Pain with Visual Analog scale.3) Independent sample T test for comparing  differences between Pre-operative, Post-operative day-3 ,day-7 and day-14. Results and interpretation of data is done.

 OUTCOME: post-operative complications like pain, mouth opening and swelling will be assessed.

 

 

 
Close